122 related articles for article (PubMed ID: 8677275)
1. Cardiac hypertrophy in copper-deficient rats is not attenuated by angiotensin II receptor antagonist L-158,809.
Lear PM; Heller LJ; Prohaska JR
Proc Soc Exp Biol Med; 1996 Jul; 212(3):284-92. PubMed ID: 8677275
[TBL] [Abstract][Full Text] [Related]
2. Atria and ventricles of copper-deficient rats exhibit similar hypertrophy and similar altered biochemical characteristics.
Lear PM; Prohaska JR
Proc Soc Exp Biol Med; 1997 Sep; 215(4):377-85. PubMed ID: 9270721
[TBL] [Abstract][Full Text] [Related]
3. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
[TBL] [Abstract][Full Text] [Related]
4. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
Ambrose J; Pribnow DG; Giraud GD; Perkins KD; Muldoon L; Greenberg BH
J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
[TBL] [Abstract][Full Text] [Related]
6. Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
Yokoyama H; Averill DB; Brosnihan KB; Smith RD; Schiffrin EL; Ferrario CM
Am J Hypertens; 2005 Jul; 18(7):922-9. PubMed ID: 16053988
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
Tokioka-Akagi T; Fujimori A; Shibasaki M; Inagaki O; Yanagisawa I
Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
[TBL] [Abstract][Full Text] [Related]
9. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
[TBL] [Abstract][Full Text] [Related]
10. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
Mizuno K; Niimura S; Katoh K; Fukuchi S
Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
[TBL] [Abstract][Full Text] [Related]
11. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep.
Segar JL; Dalshaug GB; Bedell KA; Smith OM; Scholz TD
Am J Physiol Regul Integr Comp Physiol; 2001 Dec; 281(6):R2037-47. PubMed ID: 11705791
[TBL] [Abstract][Full Text] [Related]
13. Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms.
Rossi GP; Sacchetto A; Rizzoni D; Bova S; Porteri E; Mazzocchi G; Belloni AS; Bahcelioglu M; Nussdorfer GG; Pessina AC
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):949-56. PubMed ID: 10764658
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
[TBL] [Abstract][Full Text] [Related]
15. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Leenen FH; White R; Yuan B
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406
[TBL] [Abstract][Full Text] [Related]
16. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
Ruzicka M; Yuan B; Leenen FH
Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035
[TBL] [Abstract][Full Text] [Related]
17. Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonist.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 1996; 23(6-7):576-8. PubMed ID: 8800589
[TBL] [Abstract][Full Text] [Related]
18. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
[TBL] [Abstract][Full Text] [Related]
19. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.
Dostal DE; Baker KM
Am J Hypertens; 1992 May; 5(5 Pt 1):276-80. PubMed ID: 1533768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
